These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16054733)

  • 61. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
    Hammitt LL; Bulkow L; Hennessy TW; Zanis C; Snowball M; Williams JL; Bell BP; McMahon BJ
    J Infect Dis; 2008 Dec; 198(12):1776-82. PubMed ID: 18976095
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical development of a new inactivated hepatitis A vaccine].
    Vidor E; Saliou P
    Sante; 1998; 8(5):361-8. PubMed ID: 9854014
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines.
    Orr N; Klement E; Gillis D; Sela T; Kayouf R; Derazne E; Grotto I; Balicer R; Huerta M; Aviram L; Ambar R; Epstein Y; Heled Y; Cohen D
    Vaccine; 2006 May; 24(20):4328-32. PubMed ID: 16581163
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
    Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
    Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
    Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
    J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension.
    Rosa MN; Hessel G; Alves De Tommaso AM
    Acta Gastroenterol Latinoam; 2008 Sep; 38(3):187-93. PubMed ID: 18979898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention of hepatitis A by Havrix: a review.
    Van Herck K; Van Damme P
    Expert Rev Vaccines; 2005 Aug; 4(4):459-71. PubMed ID: 16117704
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine.
    Cederna JB; Klinzman D; Stapleton JT
    Vaccine; 1999 Dec; 18(9-10):892-8. PubMed ID: 10580203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants.
    Letson GW; Shapiro CN; Kuehn D; Gardea C; Welty TK; Krause DS; Lambert SB; Margolis HS
    J Pediatr; 2004 Mar; 144(3):327-32. PubMed ID: 15001936
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees.
    Garner-Spitzer E; Kundi M; Rendi-Wagner P; Winkler B; Wiedermann G; Holzmann H; Herzog C; Kollaritsch H; Wiedermann U
    Vaccine; 2009 Jan; 27(2):197-204. PubMed ID: 18996424
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine.
    Bovier PA; Farinelli T; Loutan L
    Vaccine; 2005 Mar; 23(19):2424-9. PubMed ID: 15752828
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The immunological effects of three doses of a live attenuated hepatitis A vaccine (H2 strain) in 8 years].
    Liu HF; Zhang XJ; Zhang JL; Hao ZY; Zhang ZY; Ma JC; Chen JC; Chu J; Wang XY; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):180-1. PubMed ID: 20104771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Response to hepatitis A and B vaccination in pediatric patients with celiac disease.
    Urganci N; Kalyoncu D
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):408-11. PubMed ID: 23132166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.